Y
Yongrong Mao
Researcher at Karolinska University Hospital
Publications - 5
Citations - 180
Yongrong Mao is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Immunohistochemistry & Thymidine kinase. The author has an hindex of 4, co-authored 5 publications receiving 173 citations.
Papers
More filters
Journal ArticleDOI
Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1.
Chuanjing Wu,Rongjiang Yang,Ji Zhou,Shing Bao,Li Zou,Pinggan Zhang,Yongrong Mao,Jianping Wu,Qimin He +8 more
TL;DR: Chicken egg yolk immunoglobulins generated to a synthetic 31-amino acid peptide from the C-terminal of human HeLa thymidine kinase 1 (TK1) enzyme are suggested to be potentially useful for serological and immunohistochemical detection of TK1 as an early prognosis and for monitoring patients undergoing treatment.
Journal ArticleDOI
Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.
Qimin He,Yongrong Mao,Jainping Wu,Catrine Decker,Malik Merza,Naining Wang,Staffan Eriksson,Juan Castro,Sven Skog +8 more
TL;DR: TK1 is a reliable marker for identification of patients with grade 2 tumours and the highest number of patientsWith positively stained tumours were obtained when both TK1 and Ki-67 markers were used.
Journal ArticleDOI
A comparative study: immunohistochemical detection of cytosolic thymidine kinase and proliferating cell nuclear antigen in breast cancer.
TL;DR: It is concluded that TK1 might be a more accurate marker than PCNA for estimation of cell proliferation and malignant potentials in breast carcinomas.
Journal ArticleDOI
Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling.
TL;DR: TK1 is apparently a more reliable marker in AC patients than Ki-67, and a combination of the two markers may help identify patients of different stages and grades more efficiently, and cyclin/kinase complexes and growth factors/receptors may be useful markers in distinguishing AC from SCC.